Aktie A2P7FY FORMA THERAPEUTICS HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Forma Therapeutics Holdings, Inc.

Aktien

A2P7FY

US34633R1041

FMTX

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Novo Nordisk announces the completion of the Forma Therapeutics acquisition
Sector Update: Health Care Stocks Ending with Modest Declines
Sector Update: Health Care Stocks Sliding with Broader Friday Markets
Novo Nordisk Completes Acquisition of Forma Therapeutics; Forma Shares to be Delisted
Novo Nordisk : finalise l'acquisition de Forma Therapeutics
Novo Nordisk Completes Acquisition of Forma Therapeutics
FORMA THERAPEUTICS HOLDINGS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Forma Therapeutics Holdings, Inc. Announces Board Changes
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from NASDAQ Composite Index
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from S&P Global BMI Index
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from S&P TMI Index
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from NASDAQ Biotechnology Index
Novo Nordisk A/S (CPSE:NOVO B) completed the acquisition of Forma Therapeutics Holdings, Inc. (NasdaqGM : FMTX) from RA Capital Management, L.P. and others.
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease
FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX
Forma Therapeutics : Amendment to Initial Statement of Beneficial Ownership - Form 3/A
FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX
Nvidia, Hormel fall; Nutanix, Forma Therapeutics rise
Top Midday Gainers
Forma Therapeutics Shares Surge on Takeover by Novo Nordisk
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P7FY Aktie
  4. Nachrichten Forma Therapeutics Holdings, Inc.
  5. Andere Sprachen